trans-1-(Perfluorophenyl)prop-1-ene, trans-1-(Pentafluorophenyl)prop-1-ene
|
- $95 - $595
- Product name: trans-1-(Perfluorophenyl)prop-1-ene, trans-1-(Pentafluorophenyl)prop-1-ene
- CAS: 4683-67-4
- MF: C9H5F5
- MW: 208.13
- EINECS:
- MDL Number:MFCD19442035
- Synonyms:1,2,3,4,5,-Pentafluoro-6-[(1E)-prop-1-en-1-yl]benzene;trans-1-(Perfluorophenyl)prop-1-ene, trans-1-(Pentafluorophenyl)prop-1-ene;E-1-(Pentafluorophenyl)prop-1-ene;(E)-1,2,3,4,5-pentafluoro-6-(prop-1-en-1-yl)benzene;Benzene, 1,2,3,4,5-pentafluoro-6-(1E)-1-propen-1-yl-
3 prices
Selected condition:
Brand
- SynQuest Laboratories
Package
- 250mg
- 1g
- 5G
- ManufacturerSynQuest Laboratories
- Product number1900-3-E5
- Product descriptionE-1-(Pentafluorophenyl)prop-1-ene 97%
- Packaging250mg
- Price$95
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number1900-3-E5
- Product descriptionE-1-(Pentafluorophenyl)prop-1-ene 97%
- Packaging1g
- Price$195
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number1900-3-E5
- Product descriptionE-1-(Pentafluorophenyl)prop-1-ene 97%
- Packaging5G
- Price$595
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| SynQuest Laboratories | 1900-3-E5 | E-1-(Pentafluorophenyl)prop-1-ene 97% | 250mg | $95 | 2021-12-16 | Buy |
| SynQuest Laboratories | 1900-3-E5 | E-1-(Pentafluorophenyl)prop-1-ene 97% | 1g | $195 | 2021-12-16 | Buy |
| SynQuest Laboratories | 1900-3-E5 | E-1-(Pentafluorophenyl)prop-1-ene 97% | 5G | $595 | 2021-12-16 | Buy |
Properties
Boiling point :153.7±35.0 °C(Predicted)
Density :1.374±0.06 g/cm3(Predicted)
Density :1.374±0.06 g/cm3(Predicted)
Safety Information
| Symbol(GHS): |
![]()
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|





